Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

Decoy Therapeutics Inc.

DCOY Nasdaq SEC CIK 1615219
Follow Decoy Therapeutics Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Revenue, last quarter $227.6K
Net income −$2.4M −147.8% vs same quarter last year
EPS, diluted −$4.46 +94.5% vs same quarter last year
Operating cash flow −$2.7M −207.6% vs same quarter last year
Revenue by quarter
$0
$227.6K
Q2 25 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-$12.5M
FY24-$5.6M
FY23-$12.5M
FY22$0−$31.6M
FY21$1.8M−$12.8M
FY20$5.2M−$7.4M
FY19$3.5M−$6.9M
FY18$2M−$1.7M
FY17$1.3M−$34.4M
FY16$1M−$39.5M
FY15$0−$29.1M
FY14--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−4000%−2000%0%2000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25---
FY24---
FY23---
FY22---
FY21-−696.3%−693.8%
FY20-−148.8%−140.5%
FY19-−238.5%−200.2%
FY1877.9%−86.3%−85.6%
FY1760.3%−2724.6%−2701.7%
FY1634.4%−3946.5%−3907.6%
FY15---
FY14---
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0$10MFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$5.4M
FY24−$4.5M
FY23-
FY22-
FY21−$10.2M
FY20−$10.3M
FY19−$11.6M
FY18$4.2M
FY17−$27.8M
FY16−$32.6M
FY15−$21M
FY14-
Returned to shareholdersDividends paid and shares bought back
$0$50K$100K$150KFY15FY17FY19FY21FY23FY25
Show the numbers
YearDividends
FY25-
FY24-
FY23-
FY22-
FY21-
FY20$0
FY19$133.6K
FY18$0
FY17-
FY16-
FY15-
FY14-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Decoy Therapeutics
  • Healthcare median
−4000%−3000%−2000%−1000%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearDecoy TherapeuticsHealthcare median
FY25-−40.6%
FY24-−60.7%
FY23-−97.1%
FY22-−128.5%
FY21−693.8%−129.2%
FY20−140.5%−136.5%
FY19−200.2%−133.7%
FY18−85.6%−173.4%
FY17−2701.7%−176.7%
FY16−3907.6%−164.8%
FY15-−183.4%
FY14-−133%

News

No stories filed under Decoy Therapeutics yet - coverage appears here as the news feed clusters it.